Senior Director, Global Value Access And Pricing, Nsclc Revolution Medicines, Inc.Senior Director, Global Value Access And Pricing, NsclcRedwood City, CARemote$244,000–$305,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As the Global Value & Access lead on Disease Area Strategy Teams and governance forums, the Senior Director influences clinical development, indication sequencing, lifecycle management, launch planning, and business development decisions to maximize long-term asset value and sustainable patient access.
Director, Alliance Management Revolution Medicines, Inc.Director, Alliance ManagementRedwood City, CA$211,000–$264,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies.
Executive Director, Global Patient Safety Quality And Compliance - Pharmacovigilance Revolution Medicines, Inc.Executive Director, Global Patient Safety Quality And Compliance - PharmacovigilanceRedwood City, CA$265,000–$331,000 / yearThe responsibilities of this role include oversight of the PV-QMS, PV training strategy, PV controlled documentation, inspection and audit management, ensuring inspection readiness, Corrective Action Preventive Action (CAPA) management, Quality Assurance (QA), and maintenance of Good Clinical Practice (GCP), and Good Pharmacovigilance Practices (GVP) in partnership with GPS management, QA, and staff. This critical role will require strategic thinking, expert knowledge of global PV regulations (i.e. GCP, GVP), the ability to influence and communicate ideas effectively, results orientation, collaboration with cross-functional teams, technical expertise, and vendor management skills to ensure compliance with regulatory requirements to safeguard patient well-being.
Senior Director, Clinical Operations, Global Clinical Vendor Contracts & Budgets Revolution Medicines, Inc.Senior Director, Clinical Operations, Global Clinical Vendor Contracts & BudgetsRedwood City, CA$244,000–$305,000 / yearThe leadership role ensures alignment with strategic objectives, regulatory requirements, and study timelines as well as bringing deep expertise in managing complex trials, contract negotiations, budget development, risk management, and cross-functional collaboration to contribute to the highest quality with on time delivery of RevMed's clinical studies. A member of the Clinical Operations team Leading the Contracts and Outsourcing for all vendor relationships within Clinical Development, the Sr Director Global Vendor Outsourcing will lead the strategic identification and selection process with the teams for vendors and CROs, including scope specifications for clinical programs, and will work closely with the Sr.
Executive Director, Early Clinical Development Revolution Medicines, Inc.Executive Director, Early Clinical DevelopmentRedwood City, CA$265,000–$331,000 / yearHas demonstrated collaborate behaviors on enterprise-level strategic initiatives with a variety of internal and external partners and stakeholders - including clinical investigators/clinicians, scientists and key opinion leaders (KOLs), as well as internal groups, including other groups in development, research, business development, commercial, legal, etc. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Director, Trade Operations Pacira Pharmaceuticals, Inc.Director, Trade OperationsBrisbane, California$188,500–$240,000 / yearFull timeSummary: The Director, Trade Operations is responsible for leading both the strategic and hands-on execution of Pacira’s trade and distribution activities across all channels, including 3PL, wholesalers, specialty distributors, specialty pharmacies, and sample programs. This role collaborates cross-functionally with Finance, Supply Chain, Market Access, Marketing, and Commercial teams to support product launches, pricing changes, packaging/label updates, and supply chain planning.
Director of Commercial Marketing Mendaera, Inc.Director of Commercial MarketingSan Mateo, CA$190,000–$219,000 / yearDevelop and continuously refine clinical value propositions for each procedure and specialty Focalist competes in—grounded in procedure-level insights and translated into messaging that drives adoption and utilization across physician, care team, and hospital audiences. Develop and execute specialty-level market development programs—peer-to-peer events, case observation programs, symposia, and conference presence—designed to build procedural competency and expand the base of trained, active Focalist users.
Senior Director, Clinical Data Management (Clinical Data Systems And Ops Ex) Revolution Medicines, Inc.Senior Director, Clinical Data Management (Clinical Data Systems And Ops Ex)Redwood City, CA$244,000–$305,000 / yearThe Opportunity: The Senior Director of Clinical Data Management (CDS OpsEx) provides high-level leadership for Data Management and functions within clinical development including Information Operations, Data Products, and Clinical Data systems, focusing on strategic development, operational execution and excellence, and regulatory compliance to ensure data integrity for clinical trials. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Senior Director, Global Patient Safety Operations Revolution Medicines, Inc.Senior Director, Global Patient Safety OperationsRedwood City, CA$244,000–$305,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The Senior Director will provide broad oversight across case processing, vendor governance, safety systems and processes, aggregate reporting operations, partner interfaces, and operational readiness while developing leaders and serving as a key advisor to cross-functional stakeholders.
Director of R&D Inquis Medical, Inc.Director of R&DSan Francisco, CA$160,000–$265,000 / yearProvide hands-on engineering leadership on catheter shaft construction, braid/coil reinforcement, tip design, torque and pushability, extrusion, and material selection (e.g., Pebax, nitinol, PTFE liners). Own the technical roadmap for large-bore aspiration and mechanical thrombectomy platforms, balancing clot removal efficacy, blood loss management, deliverability/trackability, and procedural speed.
Director Of Enterprise Sales Collectly, Inc.Director Of Enterprise SalesSan Francisco, CA$330,000–$390,000 / yearCollectly applies artificial intelligence to automate workflows, accelerate cash flow, and modernize the patient financial experience; enabling healthcare organizations to operate more efficiently and focus on delivering care. This leader will manage a team of experienced Enterprise Account Executives and be responsible for driving predictable revenue performance through stronger pipeline discipline, sharper enterprise deal strategy, and rigorous execution.
Director, Hardware Lifecycle Engineering 6267-Auris Health Legal EntityDirector, Hardware Lifecycle EngineeringSanta Clara, California$189,000–$325,450 / yearBudget Management, Continuous Improvement, Contract Management, Design Thinking, Developing Others, Fact-Based Decision Making, Feasibility Studies, Inclusive Leadership, Industry Analysis, Leadership, Mechanical Engineering, Product Development, Project Management Methodology (PMM), Research and Development, SAP Product Lifecycle Management, Technical Credibility, Vendor Management The anticipated base pay range for this position is: Employees and/or eligible dependents may be eligible to participate in the following Company sponsored employee benefit programs: medical, dental, vision, life insurance, short- and long-term disability, business accident insurance, and group legal insurance.
Associate General Counsel (Director), Employment Intuitive Surgical IncAssociate General Counsel (Director), EmploymentSunnyvale, CACertain information you provide as part of the application will be used for purposes of determining whether Intuitive Surgical will need to (i) obtain an export license from the U.S. Government on your behalf (note: the government's licensing process can take 3 to 6+ months) or (ii) implement a Technology Control Plan ("TCP") (note: typically adds 2 weeks to the hiring process). U.S. Export Controls Disclaimer: In accordance with the U.S. Export Administration Regulations (15 CFR §743.13(b)), some roles at Intuitive Surgical may be subject to U.S. export controls for prospective employees who are nationals from countries currently on embargo or sanctions status.
Director of Operations Bay Area HyperbaricsDirector of OperationsLos Gatos, CA$125,000–$175,000 / yearThe ideal candidate is a hands-on healthcare leader who thrives in a fast-paced environment and has a proven track record of improving operational efficiency while building strong teams. This leadership role is responsible for operational performance, staff management, financial oversight, regulatory compliance, facility management, and delivering an exceptional patient experience.
NewDirector of Construction (February 2026) Curo Pet CareDirector of Construction (February 2026)San Francisco, CA$165,000–$225,000 / yearWe design and construct modern, highly functional veterinary hospitals (typically 3,000–5,000 square feet) in premier neighborhoods and growth markets nationwide. We have completed over 30 ground-up de novo veterinary hospital developments in recent years and maintain an active national pipeline of new builds and large-scale renovations.
Associate Director, Analytical Development & QC Revolution Medicines, Inc.Associate Director, Analytical Development & QCRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Solid understanding of relevant global and regional regulatory guidelines (FDA, EU, and ICH, etc.) as applicable to QbD, commercial process validation, commercial product launch, commercial manufacture sampling and testing, and post-approval quality control requirements.
NewAssistant Director of Advancement The International School of San FranciscoAssistant Director of AdvancementSan Francisco, CAFull timeThis role offers the opportunity for close, collaborative work and problem-solving with a small team of dedicated and dynamic development professionals, and involves developing and implementing plans that help International achieve its annual fundraising and participation goals through philanthropic support from current parents, alumni, grandparents, parents of alumni, faculty, staff, and friends of the school. This role works on all dimensions of International's annual giving efforts—including solicitation strategy, donor stewardship, volunteer engagement, event planning, and donor communications—and works in partnership with the Director of Advancement, the Advancement team and volunteers to develop meaningful opportunities for community engagement and philanthropic support.
Director of Housing Development Oakland or Foster City or Watsonville Midpen Housing CorporationDirector of Housing Development Oakland or Foster City or WatsonvilleOakland, CA$193,600–$217,800 / yearSince 1970, we have been committed to our mission: to provide safe, affordable housing of high quality to those in need; establish stability and opportunity in the lives of residents; and foster diverse communities that allow people from all ethnic, social, and economic backgrounds to live in dignity, harmony, and mutual respect. The Director of Housing Development is responsible for managing a team of Real Estate Development personnel including Senior Project Managers, Project Managers, Associate Project Managers and/or Project Associates.
Director Of Social Services Bonita House, IncDirector Of Social ServicesOakland, CAReporting to the Executive Director and serving as a member of the Executive Team, this position ensures high-quality, person-centered, recovery-oriented services that advance organizational goals, clinical integrity, regulatory compliance, fiscal stewardship, and positive outcomes for participants, staff, and community partners. This position provides direct supervision to program directors, managers, and/or other designated leadership staff within assigned programs and has overall responsibility for leadership support, accountability, and performance outcomes across the portfolio.
Director of Asset Management, Real Estate Transactions Foster City, Oakland Midpen Housing CorporationDirector of Asset Management, Real Estate Transactions Foster City, OaklandFoster City, CA$175,000–$195,000 / yearEducation and Experience: Bachelor's Degree in Finance, Community Development, Economics, Urban Planning, or related field plus eight years' progressively responsible experience in low-income housing development, real estate transactions, or asset management, including at least three years of people management experience, or an equivalent combination of education and relevant work experience. Monitor available Requests for Proposals (RFP's) and Notices of Funds Available (NOFA's) for available funds from public lenders, including but not limited to funds for capital improvement projects, refinancing, loan modifications, Housing Assistance Payments (HAP) Contracts, energy grants and rebate incentive programs, and other capital events in the portfolio.